Victory Capital Management Inc. Reduces Stock Position in GE HealthCare Technologies Inc. $GEHC

Victory Capital Management Inc. reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 833,584 shares of the company’s stock after selling 8,315 shares during the quarter. Victory Capital Management Inc. owned 0.18% of GE HealthCare Technologies worth $62,602,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Dodge & Cox increased its position in shares of GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares in the last quarter. Norges Bank purchased a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at approximately $468,120,000. Holocene Advisors LP boosted its stake in GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after purchasing an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. purchased a new stake in GE HealthCare Technologies during the 2nd quarter worth approximately $80,755,000. Finally, Balyasny Asset Management L.P. acquired a new position in GE HealthCare Technologies during the 2nd quarter valued at approximately $58,388,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on GEHC. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Bank of America increased their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Finally, BTIG Research lifted their target price on GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Stock Down 3.7%

Shares of GEHC stock opened at $74.27 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $89.77. The stock has a market cap of $33.85 billion, a P/E ratio of 16.29, a P/E/G ratio of 1.69 and a beta of 1.03. The stock has a 50 day moving average of $81.81 and a 200 day moving average of $78.54. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same period in the previous year, the business posted $1.45 EPS. The business’s revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.